In Nation on the Take, Wendell Potter and Nick Peniman talk about the extent to which the U.S. political system has been hijacked to serve the interests of big business.

On campaign finance:

It is the knowledge that an elected official has of who is writing the check, who’s going to be there if and when this person decides to run for reelection, that they can expect another campaign check if they have demonstrated that they are voting the way the donor wants…One of the things I used to do in my job in the insurance industry was administer the political action committee and there’s a lot of thought that goes into who you write checks to, and you want to make sure that you’re writing checks to people who can be persuaded to see things from your perspective and vote for the things that you want them to or vote against things you are not supporting when the time comes.

On the finance industry:

Their contributions have been extensive and continue to be so and certainly the legislation that was finally approved by Congress, the Dodd-Frank Act, and other pieces of legislation that have been proposed to regulate the financial industry were written to a large extent by the lobbyists for financial institutions. And we point out in the book how the interest of the banks and mortgage companies were served first, and the challenges and the difficulties that a lot of average homeowners are having even yet today to keep their homes out of foreclosure… I remember watching Bill Moyers’ show a number of years ago when he had Gretchen Morgenson on, the chief financial reporter for The New York Times, and when she was asked whether or not Dodd-Frank had tackled the big stuff, she said, “No, absolutely not. It hasn’t and we could likely have another financial crisis as a result.” And when asked why, she said, “Because the banks have hundreds of lobbyists in Washington and the American people have none.”

On the pharmaceutical industry:

Despite the promises that Barack Obama had made when he was running for president that at the very least Medicare should have the ability to negotiate with drug companies to lower prices for Medicare beneficiaries — and he also campaigned on making it lawful for Americans to reimport medications from Canada where drugs are a lot cheaper — despite those campaign promises, President Obama gave both of those up under intense pressure from the pharmaceutical industry to be able to get something passed…Yes, few people realize that even though the pharmaceutical industry talks a great deal about how much they spend on research and development, the companies spend far more on sales and marketing than research. In fact, most of the research is done at taxpayers’ expense by governmental or quasigovernmental entities like the National Institutes of Health and universities that get funding from the government. So much of the research is done at the taxpayers’ expense, and rightfully so. But the companies themselves spend relatively little on research. They take the research typically and invest in the development of medications but most of the prescription medications are developed at publicly funded institutions. And in a sense we pay twice as a consequence. We pay for the research as taxpayers and of course we pay dearly whenever we need the medication.

On the food industry:

We want our kids to eat healthy, period. That should just be a no-brainer, a fait accompli in a good society. But instead, because of the power of money in politics, it becomes hyperpoliticized, a massive battle with all kinds of very powerful people who make a lot of money trying to manipulate the food items that show up on our kids’ plates at their school cafeteria.